OCULAR THERAPEUTIX, INC - Common Stock (OCUL)

CUSIP: 67576A100

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
214,467,875
Total 13F shares
18,785,162
Share change
-701,571
Total reported value
$129,054,713
Put/Call ratio
80%
Price per share
$6.87
Number of holders
70
Value change
-$2,936,943
Number of buys
39
Number of sells
24

Quarterly Holders Quick Answers

What is CUSIP 67576A100?
CUSIP 67576A100 identifies OCUL - OCULAR THERAPEUTIX, INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of OCUL - OCULAR THERAPEUTIX, INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
1.7%
3,711,552
$18,372,000 30 Jun 2016
13F
JENNISON ASSOCIATES LLC
13F
Company
1.4%
2,972,606
$14,714,000 30 Jun 2016
13F
Versant Venture Management, LLC
13F
Company
1%
2,215,384
$10,966,151 30 Jun 2016
13F
SV Health Investors, LLC
13F
Company
0.9%
1,932,607
$9,566,000 30 Jun 2016
13F
FEDERATED HERMES, INC.
13F
Company
0.65%
1,396,287
$6,912,000 30 Jun 2016
13F
Polaris Venture Management Co. V, L.L.C.
13F
Company
0.47%
998,713
$4,944,000 30 Jun 2016
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.45%
961,136
$4,758,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
0.36%
775,611
$3,839,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
0.22%
479,309
$2,373,000 30 Jun 2016
13F
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.
13F
Company
0.16%
353,464
$1,750,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
0.14%
294,608
$1,458,000 30 Jun 2016
13F
COLUMBUS CIRCLE INVESTORS
13F
Company
0.13%
278,785
$1,380,000 30 Jun 2016
13F
Opaleye Management Inc.
13F
Company
0.12%
260,000
$1,287,000 30 Jun 2016
13F
J.P. Morgan Private Wealth Advisors LLC
13F
Company
0.12%
256,045
$1,267,000 30 Jun 2016
13F
BAILARD, INC.
13F
Company
0.1%
219,752
$1,088,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
0.1%
205,309
$1,014,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
0.09%
193,804
$959,000 30 Jun 2016
13F
NOTTINGHAM ADVISORS, INC.
13F
Company
0.09%
189,266
$937,000 30 Jun 2016
13F
DEUTSCHE BANK AG\
13F
Company
0.06%
128,187
$634,000 30 Jun 2016
13F
COWEN INC.
13F
Company
0.06%
126,904
$628,000 30 Jun 2016
13F
MORGAN STANLEY
13F
Company
0.05%
98,606
$488,000 30 Jun 2016
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.04%
85,259
$422,000 30 Jun 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.04%
76,935
$381,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.04%
76,212
$377,000 30 Jun 2016
13F
Polar Capital LLP
13F
Company
0.03%
74,873
$371,000 30 Jun 2016
13F
EDMOND DE ROTHSCHILD (SUISSE) S.A.
13F
Company
0.03%
70,000
$346,000 30 Jun 2016
13F
EDMOND DE ROTHSCHILD HOLDING S.A.
13F
Company
0.03%
70,000
$346,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
0.03%
61,473
$304,000 30 Jun 2016
13F
CITADEL ADVISORS LLC
13F
Company
0.03%
57,791
$286,000 30 Jun 2016
13F
D. E. Shaw & Co., Inc.
13F
Company
0.03%
56,887
$282,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
0.03%
55,915
$277,000 30 Jun 2016
13F
ROYAL BANK OF CANADA
13F
Company
0.02%
49,210
$244,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.02%
47,814
$237,000 30 Jun 2016
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.02%
47,300
$234,000 30 Jun 2016
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.02%
45,150
$223,000 30 Jun 2016
13F
Rhenman & Partners Asset Management AB
13F
Company
0.02%
40,000
$198,000 30 Jun 2016
13F
A.R.T. Advisors, LLC
13F
Company
0.02%
38,433
$190,000 30 Jun 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.02%
37,928
$188,000 30 Jun 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.02%
37,539
$186,000 30 Jun 2016
13F
ALPS ADVISORS INC
13F
Company
0.02%
34,792
$172,000 30 Jun 2016
13F
Veritable, L.P.
13F
Company
0.01%
30,143
$149,000 30 Jun 2016
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.01%
28,997
$144,000 30 Jun 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.01%
27,300
$135,000 30 Jun 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
0.01%
25,268
$125,000 30 Jun 2016
13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC
13F
Company
0.01%
22,354
$111,000 30 Jun 2016
13F
ProShare Advisors LLC
13F
Company
0.01%
20,623
$102,000 30 Jun 2016
13F
Schonfeld Strategic Advisors LLC
13F
Company
0.01%
19,670
$97,000 30 Jun 2016
13F
Swiss National Bank
13F
Company
0.01%
19,000
$94,000 30 Jun 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.01%
18,570
$92,000 30 Jun 2016
13F
CREDIT SUISSE AG/
13F
Company
0.01%
17,451
$86,000 30 Jun 2016
13F

Institutional Holders of OCULAR THERAPEUTIX, INC - Common Stock (OCUL) as of Q3 2016

As of 30 Sep 2016, OCULAR THERAPEUTIX, INC - Common Stock (OCUL) was held by 70 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 18,785,162 shares. The largest 10 holders included FMR LLC, JENNISON ASSOCIATES LLC, Versant Venture Management, LLC, SV Life Sciences Advisers, LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT GROUP LLP, BlackRock Fund Advisors, VANGUARD GROUP INC, MORGAN STANLEY, and COLUMBUS CIRCLE INVESTORS. This page lists 70 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
74
Q3 2016 holders
70
Holder diff
-4
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .